Intellia Therapeutics, Inc. (NTLA)

NGM – Real Time Price. Currency in USD

12.06

+0.04 (0.29%)

Market open: Aug 12, 2026, 12:59 PM EDT

12.04

+0.02 (0.18%)

Previous after-hours: Aug 11, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

68M

58M

36M

52M

Cost of goods sold

-16M

-10M

-9M

-8M

Gross Profit

52M

48M

27M

45M

Operating expenses (excl. COGS)

-493M

-582M

-543M

-503M

Operating Income

-441M

-534M

-515M

-458M

Non-operating income, total

28M

15M

34M

-16M

Pretax income

-413M

-519M

-481M

-474M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-413M

-519M

-481M

-474M

Discontinued operations

Net income

-413M

-519M

-481M

-474M

Dilution adjustment

Preferred dividends

Intellia Therapeutics, Inc. (NTLA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Intellia Therapeutics, Inc. (NTLA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Intellia Therapeutics, Inc. (NTLA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Intellia Therapeutics, Inc. (NTLA)

Income Statement (Annual)

Income Statement (Annual)